Aortic valve replacement with stentless porcine aortic bioprosthesis

Early changes in left ventricular function after aortic valve replacement for isolated aortic stenosis

To assess the immediate effects of aortic valve replacement (AVR) for valvular aortic stenosis (AS) on left ventricular (LV) systolic and diastolic function and global hemodynamics, 17 patients with AS underwent transesophageal echocardiography combined with high-fidelity LV pressure recording and thermodilution cardiac output measurements before cardiopulmonary bypass and 0.5, 6, 12, and 20 hours after AVR. Compared with results before bypass, LV systolic function had already changed 30 minutes after AVR, and remained constant thereafter: peak LV systolic wall stress decreased (from 210 +/- 60 to 130 +/- 40 g.cm-2), peak rate of dimension shortening increased (from 7.3 +/- 2.2 to 9.7 +/- 2.1 cm.s-1), both p < 0.01. Peak segmental external power thus remained constant (16.6 +/- 6.7 vs 17.7 +/- 7.6 mW.cm-3); p = NS. Changes in LV diastolic function and global hemodynamics were delayed. The peak rate of ventricular pressure decrease, normalized to developed end-systolic pressure, increased (from 15 +/- 3.2 to 19 +/- 5.2 s-1) by 6 hours. The minimal ventricular pressure of early diastole decreased (from 8.9 +/- 4.9 to 4.3 +/- 3.7 mm Hg), the peak rate of dimension lengthening of early diastole increased (from 6.0 +/- 3.0 to 8.8 +/- 2.0 cm.s-1), and LV stroke volume index increased (from 24 +/- 7 to 31 +/- 6 ml.m-2) by 12 hours, all p < 0.01. LV incoordination, defined as the dimension changes during isovolumic periods, had also improved significantly at 20 hours. Heart rate and LV enddiastolic dimension did not change.(ABSTRACT TRUNCATED AT 250 WORDS)

Initial clinical experience with the Toronto Stentless Porcine Valve

We report our initial experience from April 1992 to November 1993 with a stentless porcine valve (Toronto SPV Valve, St. Jude Medical) for aortic valve replacement (AVR) in 21 consecutive patients and compare this group to a matched cohort that underwent AVR with a Hancock II (Medtronic) bioprosthesis. There were no hospital deaths in either group. Postoperative hospitalization was 5.5 +/- 0.8 versus 7.0 +/- 2.3 days (p = 0.004). Aortic cross-clamp time was 114.5 +/- 15.7 min in the SPV group and 96.0 +/- 25.0 min in the Hancock II group (p = 0.003). Complications in the SPV group were: one patient suffered perioperative infarction, one patient required late reoperation for left main stenosis, and one patient died suddenly following femoral thrombectomy at another center. Complications in the Hancock II group included: one patient with postoperative low output syndrome, and two late deaths (one from an aortic dissection and the other from chronic liver disease secondary to alcohol abuse). Comparison data indicate that the average size valve implanted in the SPV group was higher than in the Hancock II group (26.3 +/- 1.9 vs 24.0 +/- 1.9, p = 0.001). In the SPV group, 16 patients had 0 or trivial regurgitation and 1+ regurgitation was seen in 5 patients; regurgitation did not change over a 12-month follow-up. We observed a decrease in gradients over time (p < 0.01). Our results are compatible with a hypothesis that the ventricle undergoes remodeling over time, once the obstruction is relieved. We think the stentless design is an important feature that allows this to occur.(ABSTRACT TRUNCATED AT 250 WORDS)

Present status of reconstructive surgery for aortic valve disease

Most surgical techniques for reconstruction of the aortic valve, although described a long time ago, are now feasible with satisfactory results. The general surgical principles for successful reconstruction, and the operative techniques of annuloplasty, commissurotomy, free edge resuspension, unrolling and thinning, and cusp extension are described. Methods for intraoperative evaluation of the repaired valve are also described. Between August 1988 and April 1992, 166 patients underwent aortic valve reconstruction with a 3.2% hospital and 1.2% late mortality. There were no thromboembolic events in the patients with isolated aortic valve repair. The reoperation rate was 6.5%. Echocardiographic study at last follow-up showed stable results at 4 years maximum follow-up.

Stentless aortic bioprosthesis? The way forward: early experience with the Edwards valve

Tissue valve degeneration has been variably attributed to preservation and fixation methods. Additionally, a rigid valve ring might contribute to valve failure. The use of a nonstented porcine valve in the aortic position has clear hemodynamic advantages, and the lack of a stent may favorably influence long-term function. We have implanted stentless aortic valves (Prima valve) in 31 patients. There were 17 men. The mean age was 71.5 years (range, 50 to 83 years). After sculpturing of the sinuses the valve is positioned below the coronary arteries. Valve sizes ranged from 19 to 27 mm. There were no early or late deaths. Mean follow-up to date is 8.9 months (range, 4 weeks to 15 months). Early hemodynamic follow-up using Doppler echocardiography shows average peak systolic and mean gradients of 20.4 mm Hg and 8.6 mm Hg, respectively, at 4 weeks in 26 patients, with no significant change in 13 patients at 6 months. All patients are currently in New York Heart Association class I or II. Our early experience of stentless aortic valves shows them to be reliable with a satisfactory early hemodynamic profile. Their use in the elderly may conserve homografts for children and the young.

Modern cardiac valve devices--bioprostheses and mechanical prostheses: state of the art

The choice of bioprostheses and mechanical prostheses as valvular substitutes for cardiac valve replacement surgery has existed for over 20 years. The extensive developments over the past three decades have been introduced to reduce or eliminate valve related complications, namely thromboembolism, anticoagulant related hemorrhage, and structural failure, as well as to optimize hemodynamic performance. The biological valvular prostheses, namely porcine aortic or bovine pericardium, have been developed with tissue preservation, together with stent designs, that contribute to preservation of anatomical characteristics and biomechanical properties of the leaflets. The mechanical prostheses have been developed to eliminate structural failure, to facilitate prevention of blood status and thrombus formation, to facilitate radiopacity for evaluation of prosthesis function, and to facilitate intraoperative leaflet positioning. The implantation of the various present generation bioprostheses and mechanical prostheses requires special considerations to avoid technical complications and support ventricular performance. The studies of biological and mechanical prostheses, both randomized and nonrandomized, as well as specific prosthesis assessments, have contributed to the establishment of indications for types of prostheses. Bioprostheses have a high risk of structural failure and reoperation, while mechanical prostheses have a high risk of thromboembolism and anticoagulant hemorrhage. Within the bioprostheses population, the risk factors for structural valve deterioration are younger age and mitral prosthesis. Older patients (> 65 years of age) have a greater risk of valve related complications with mechanical prostheses, while younger patients (< 40 years of age) are at greater risk with bioprostheses. Comparison of large bioprostheses and mechanical prostheses populations by age groups revealed that regardless of the differences in the freedom from structural valve deterioration, the freedom from treatment failure (valve related mortality and permanent impairment from thromboembolism, anticoagulant hemorrhage, and septal emboli from prosthetic valve endocarditis) is essentially the same for mechanical prostheses and bioprostheses at 10 years. The quality of life is superior with bioprostheses, while patient survival and total valve related morbidity/mortality are similar with both types of prostheses.

Stentless porcine and pericardial valve in aortic position

Fifty-seven patients underwent aortic valve replacement with a stentless glutaraldehyde-fixed bioprosthesis; 27 received a porcine aortic valve and 30 had a bovine pericardial valve. Two groups of 30 patients each who had aortic valve replacement with a tilting-disc mechanical valve or a stented porcine bioprosthesis served as controls. There were no differences in sex, body surface area, valve lesion, and valve size among the four groups. Results were assessed on a Doppler-based determination of maximum velocity across the valve, aortic valve area, and degree of valve regurgitation. Velocity across the valve was significantly less with stentless pericardial valves than with stentless porcine valves, stented bioprostheses, and mechanical valves. Stentless valves had a significantly larger aortic valve area when compared with stented valves. Mild central aortic insufficiency was detected more often with stentless pericardial than with stentless porcine bioprostheses (p = 0.04). Stentless valves showed a higher incidence of complete atrioventricular block when compared with stented valves (p = 0.04). Long-term studies are now warranted to assess the durability of both types of stentless valves.

A model of the geometrical changes in aortic valve leaflets in response to leaflet extension and variable boundary conditions

The function, deformation and performance of heart valve leaflets are dependent on the material properties and the geometry of the leaflet. As the leaflet acts as a constrained membrane the geometry is dependent on the boundary condition applied to the leaflet and any permanent extension of the leaflet. Both of these factors are varied during the preparation of frame-mounted porcine bioprosthetic heart valves and surgical insertion of free-sewn valves. This can result in abnormal geometry and function. A mathematical model has been developed which describes these changes in geometry of a cylindrical leaflet as a function of the diameter of the aortic root (boundary conditions) and the length (or permanent extension) of the leaflet. Both the angle of inclination and the radius of curvature of the cylindrical leaflet were reduced with increased leaflet length or decreased aortic diameter. Agreement was found between the model predictions and experimental observations in porcine bioprosthetic heart valves, where abnormal leaflet geometries are produced by non-physiological boundary conditions and permanent set of the leaflets by fixation with glutaraldehyde. The general solutions developed in this model allow leaflet geometries to be predicted for a range of conditions in free-sewn and frame-mounted valves.

Unstented and partial stented bioprostheses for aortic valve replacement--up to 6 years of follow-up

Since January 8, 1985, three different designs of unstented (type A, n = 9) and partial stented (type B, n = 4; and type C, n = 3) glutaraldehyde preserved porcine aortic valves were used for aortic valve replacement in 16 patients with acquired aortic valve lesions. Type A and type B prostheses were implanted using a two suture row technique. In type C prostheses, only a single suture row was necessary for implantation, facilitating surgery considerably. In all patients, the fully flexible commissures of the bioprostheses were secured to the aortic wall of the recipient. There was no hospital mortality. Two patients with type A bioprostheses died due to noncardiac causes, 4 and 24 months postoperatively. One bioprosthesis in this group had to be replaced after 3 months because of insufficiency. Serial Doppler echocardiographic studies were performed up to 6 years after implantation. No significant leaflet calcification was observed. In three type A bioprostheses, a mild insufficiency without progression was recorded. The latest mean/peak transprosthetic pressure gradients were: type A: 6 +/- 4 mmHg/12 +/- 6 mmHg; type B: 6 +/- 3 mmHg/14 +/- 5 mmHg; and type C: 11 +/- 5 mmHg/18 +/- 8 mmHg. The functional results of the type A and type B bioprostheses have proven to be satisfactory. The slightly higher pressure gradients in patients with a type C bioprosthesis give rise to further refinements of its design. These results confirm the usefulness of imitating normal anatomy by using unstented or partial stented bioprostheses.

Aortic valve/root interactions in porcine hearts: implications for bioprosthetic valve sizing

The implantation of aortic allografts as well as stentless, freehand porcine xenograft valves requires proper sizing of the graft for the recipient aortic root. To visualize the aortic valve in motion and measure the cyclic expansion of the aortic root, we developed an isolated porcine heart model and a computerized three-dimensional reconstruction technique. Dynamic and static expansions of the aortic root were obtained from beating and arrested porcine hearts, and additional static expansions at varying pressures were measured from reconstructed three-dimensional models of valves obtained with high-resolution magnetic resonance imaging. Measurements of aortic root expansion have shown that it is highly dependent upon the pressures imposed on the heart. Although the aortic root expanded by only 5% between systolic pressures of 60 and 100 mmHg, the total expansion was up to 40% between rest and cyclic pressurizing to 100 mmHg. This data suggest that unstented xenograft valves should be sized 30% to 40% larger than the collapsed size of the recipient aorta. Proper sizing of valves on stents should also be attempted to reduce the large amount of leaflet redundancy that current stenting techniques produce.

Indications and limitations of aortic valve reconstruction

To elucidate the value of conservative operation for aortic regurgitation, all consecutive patients operated on between July 1988 and July 1990 were reviewed. Of 251 patients with aortic regurgitation, 107 (42.6%) had nonprosthetic operation. The mean age was 23 years, and 90 patients (84.1%) were rheumatic. Two techniques were used: repair (annular and leaflet plasties, 69 cases) and cusp extension with glutaraldehyde-treated pericardium (25 bovine, 13 autologous). There were two hospital deaths (1.8%), both in the repair group, and no late deaths or embolic events. Only 5 patients (4.7%) were anticoagulated. In the repair group there were 12 reoperations, four (5.9%) due to aortic and eight to mitral dysfunction. In the cusp extension group there were two reoperations due to mitral dysfunction. Echocardiographic follow-up showed better results with cusp extension. In conclusion, conservative operation for aortic regurgitation is possible in a high percentage of young rheumatic patients and does not require anticoagulation. Cusp extension is more reliable than repair in terms of early results, although its long-term durability is not yet known.